









市场行情
/
股票
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

6.800USD

+0.210+3.19%

收盘 12/22, 16:00（美东）报价延迟15分钟

317.44M总市值

亏损市盈率 TTM



Quanterix Corp

6.800

+0.210+3.19%

概览公司财务分析

概览

公司

财务

分析

关于 Quanterix Corp 公司

Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Quanterix Corp简介



公司代码QTRX

公司名称Quanterix Corp

上市日期Dec 07, 2017

CEOToloue (Masoud)

员工数量471

证券类型Ordinary Share

年结日Dec 07

公司地址900 Middlesex Turnpike

城市BILLERICA

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编01821

电话16173019400

网址https://www.quanterix.com/

公司代码QTRX

上市日期Dec 07, 2017

CEOToloue (Masoud)

Quanterix Corp公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

285.62K

-0.52%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

138.14K

+3.81%

Ms. Karen A. Flynn

Independent Director

26.41K

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

14.84K

-1.52%

Mr. Scott Mendel

Director

6.27K

+49.75%

Dr. Myla P. Lai-Goldman, M.D.

Director

5.02K

+70.88%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

3.96K

-79.63%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Dr. Garret Hampton, Ph.D.

Independent Director

Dr. Alan Sachs, M.D., Ph.D.

Independent Director

名称

名称/职务

职务

持股

持股变动

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

285.62K

-0.52%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

138.14K

+3.81%

Ms. Karen A. Flynn

Independent Director

26.41K

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

14.84K

-1.52%

Mr. Scott Mendel

Director

6.27K

+49.75%

Dr. Myla P. Lai-Goldman, M.D.

Director

5.02K

+70.88%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Product revenue

16.83M

68.83%

Service and other revenue

7.09M

28.99%

Collaboration and license revenue

532.00K

2.18%

地区USD

名称

营收

占比

North America

14.67M

60.01%

EMEA

6.51M

26.61%

Asia Pacific

3.27M

13.38%

业务

地区

业务USD

名称

营收

占比

Product revenue

16.83M

68.83%

Service and other revenue

7.09M

28.99%

Collaboration and license revenue

532.00K

2.18%

股东统计

更新时间: 11月21日周五

持股股东

股东类型

持股股东

占比

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.67%

Telegraph Hill Partners

5.36%

其他

67.01%

持股股东

占比

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.67%

Telegraph Hill Partners

5.36%

其他

67.01%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

36.88%

Investment Advisor

22.56%

Hedge Fund

12.00%

Individual Investor

5.94%

Private Equity

5.36%

Research Firm

4.36%

Pension Fund

0.44%

Bank and Trust

0.20%

Family Office

0.13%

其他

12.12%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

384

34.11M

73.41%

-9.53M

2025Q2

391

36.46M

81.18%

-12.95M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

2023Q2

388

36.74M

98.24%

-9.95M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Portolan Capital Management, L.L.C.

3.63M

7.82%

+670.23K

+22.62%

Jun 30, 2025

Columbia Threadneedle Investments (UK)

3.13M

6.73%

+128.33K

+4.28%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.65M

5.7%

-36.11K

-1.35%

Jun 30, 2025

The Vanguard Group, Inc.

2.53M

5.44%

+3.27K

+0.13%

Jun 30, 2025

Walt (David R)

1.86M

4.01%

+2.15K

+0.12%

Jul 31, 2025

Invenomic Capital Management LP

1.14M

2.46%

+242.86K

+26.92%

Jun 30, 2025

William Blair Investment Management, LLC

1.13M

2.43%

+21.92K

+1.98%

Jun 30, 2025

Easterly Investment Partners LLC

1.08M

2.33%

-241.99K

-18.25%

Jun 30, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.63%

iShares Micro-Cap ETF

0.04%

Fidelity Enhanced Small Cap ETF

0.03%

Avantis US Small Cap Equity ETF

0.03%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

iShares Biotechnology ETF

0.02%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

iShares Russell 2000 Value ETF

0.01%

Global X Russell 2000 ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

占比0.63%

iShares Micro-Cap ETF

占比0.04%

Fidelity Enhanced Small Cap ETF

占比0.03%

Avantis US Small Cap Equity ETF

占比0.03%

Invesco RAFI US 1500 Small-Mid ETF

占比0.02%

iShares Biotechnology ETF

占比0.02%

Proshares Ultra Russell 2000

占比0.01%

ProShares UltraPro Russell2000

占比0.01%

iShares Russell 2000 Value ETF

占比0.01%

Global X Russell 2000 ETF

占比0.01%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Quanterix Corp的前五大股东是谁？



Quanterix Corp 的前五大股东如下：
Portolan Capital Management, L.L.C.持有股份：3.63M，占总股份比例：7.82%。
Columbia Threadneedle Investments (UK)持有股份：3.13M，占总股份比例：6.73%。
BlackRock Institutional Trust Company, N.A.持有股份：2.65M，占总股份比例：5.70%。
The Vanguard Group, Inc.持有股份：2.53M，占总股份比例：5.44%。
Walt (David R)持有股份：1.86M，占总股份比例：4.01%。